Akm E. Ullah

Array ( [id] => 8252453 [patent_doc_number] => 20120156775 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-21 [patent_title] => 'Cells Useful for Immuno-Based Botulinum Toxin Serotype A Activity Assays' [patent_app_type] => utility [patent_app_number] => 13/339225 [patent_app_country] => US [patent_app_date] => 2011-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 66854 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0156/20120156775.pdf [firstpage_image] =>[orig_patent_app_number] => 13339225 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8252454 [patent_doc_number] => 20120156776 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-21 [patent_title] => 'Cells Useful for Immuno-Based Botulinum Toxin Serotype A Activity Assays' [patent_app_type] => utility [patent_app_number] => 13/339274 [patent_app_country] => US [patent_app_date] => 2011-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 66822 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0156/20120156776.pdf [firstpage_image] =>[orig_patent_app_number] => 13339274 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8896547 [patent_doc_number] => 08476068 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-07-02 [patent_title] => 'Cells useful for immuno-based botulinum toxin serotype A activity assays' [patent_app_type] => utility [patent_app_number] => 13/339166 [patent_app_country] => US [patent_app_date] => 2011-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 66772 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 154 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13339166 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9239021 [patent_doc_number] => 08603812 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-12-10 [patent_title] => 'Cells useful for immuno-based botulinum toxin serotype A activity assays' [patent_app_type] => utility [patent_app_number] => 13/339260 [patent_app_country] => US [patent_app_date] => 2011-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 66774 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 162 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13339260 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8347374 [patent_doc_number] => 20120208271 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-16 [patent_title] => 'Cells Useful for Immuno-Based Botulinum Toxin Serotype A Activity Assays' [patent_app_type] => utility [patent_app_number] => 13/339106 [patent_app_country] => US [patent_app_date] => 2011-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 66762 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13339106 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8265308 [patent_doc_number] => 20120164728 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-28 [patent_title] => 'Cells Useful for Immuno-Based Botulinum Toxin Serotype A Activity Assays' [patent_app_type] => utility [patent_app_number] => 13/339248 [patent_app_country] => US [patent_app_date] => 2011-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 66833 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13339248 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8347365 [patent_doc_number] => 20120208272 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-16 [patent_title] => 'Cells Useful for Immuno-Based Botulinum Toxin Serotype A Activity Assays' [patent_app_type] => utility [patent_app_number] => 13/339237 [patent_app_country] => US [patent_app_date] => 2011-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 66768 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13339237 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8240396 [patent_doc_number] => 20120149103 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-14 [patent_title] => 'Cells Useful for Immuno-Based Botulinum Toxin Serotype A Activity Assays' [patent_app_type] => utility [patent_app_number] => 13/339056 [patent_app_country] => US [patent_app_date] => 2011-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 66824 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13339056 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8240393 [patent_doc_number] => 20120149105 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-14 [patent_title] => 'Cells Useful for Immuno-Based Botulinum Toxin Serotype A Activity Assays' [patent_app_type] => utility [patent_app_number] => 13/339128 [patent_app_country] => US [patent_app_date] => 2011-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 66855 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13339128 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8846068 [patent_doc_number] => 08455247 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-06-04 [patent_title] => 'Cells useful for immuno-based botulinum toxin serotype A activity assays' [patent_app_type] => utility [patent_app_number] => 13/339079 [patent_app_country] => US [patent_app_date] => 2011-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 66787 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 160 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13339079 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9239022 [patent_doc_number] => 08603813 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-12-10 [patent_title] => 'Cells useful for immuno-based botulinum toxin serotype A activity assays' [patent_app_type] => utility [patent_app_number] => 13/339268 [patent_app_country] => US [patent_app_date] => 2011-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 66770 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 158 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13339268 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8252448 [patent_doc_number] => 20120156774 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-21 [patent_title] => 'Cells Useful for Immuno-Based Botulinum Toxin Serotype A Activity Assays' [patent_app_type] => utility [patent_app_number] => 13/339211 [patent_app_country] => US [patent_app_date] => 2011-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 66827 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0156/20120156774.pdf [firstpage_image] =>[orig_patent_app_number] => 13339211 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9344835 [patent_doc_number] => 08663982 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-03-04 [patent_title] => 'Cells useful for immuno-based botulinum toxin serotype A activity assays' [patent_app_type] => utility [patent_app_number] => 13/339232 [patent_app_country] => US [patent_app_date] => 2011-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 66757 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 157 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13339232 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9401514 [patent_doc_number] => 08691566 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2014-04-08 [patent_title] => 'Cells useful for immuno-based botulinum toxin serotype a activity assays' [patent_app_type] => utility [patent_app_number] => 13/339264 [patent_app_country] => US [patent_app_date] => 2011-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 66866 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 150 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13339264 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8465576 [patent_doc_number] => 20120270744 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-25 [patent_title] => 'METHODS TO DETERMINE IF A SUBJECT WILL RESPOND TO A BCR-ABL INHIBITOR' [patent_app_type] => utility [patent_app_number] => 13/330142 [patent_app_country] => US [patent_app_date] => 2011-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 44 [patent_no_of_words] => 30496 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13330142 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8884695 [patent_doc_number] => 20130157879 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-06-20 [patent_title] => 'BIOMARKER DACT1 FOR GASTRIC CANCER' [patent_app_type] => utility [patent_app_number] => 13/328785 [patent_app_country] => US [patent_app_date] => 2011-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 18052 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13328785 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8359533 [patent_doc_number] => 20120214679 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-23 [patent_title] => 'METHODS AND SYSTEMS FOR EVALUATING THE SENSITIVITY OR RESISTANCE OF TUMOR SPECIMENS TO CHEMOTHERAPEUTIC AGENTS' [patent_app_type] => utility [patent_app_number] => 13/304990 [patent_app_country] => US [patent_app_date] => 2011-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 51025 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13304990 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8253021 [patent_doc_number] => 20120157334 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-21 [patent_title] => 'MIRNAS AS BIOMARKERS FOR DISTINGUISHING BENIGN FROM MALIGNANT THYROID NEOPLASMS' [patent_app_type] => utility [patent_app_number] => 13/299226 [patent_app_country] => US [patent_app_date] => 2011-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 117603 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0157/20120157334.pdf [firstpage_image] =>[orig_patent_app_number] => 13299226 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7807996 [patent_doc_number] => 20120058950 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-08 [patent_title] => 'DETECTION OF NEUROPEPTIDES ASSOCIATED WITH PELVIC PAIN DISORDERS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/295036 [patent_app_country] => US [patent_app_date] => 2011-11-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 9623 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20120058950.pdf [firstpage_image] =>[orig_patent_app_number] => 13295036 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8042255 [patent_doc_number] => 20120070862 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-22 [patent_title] => 'METHODS FOR PRODUCING UNIQUELY DISTINCT NUCLEIC ACID TAGS' [patent_app_type] => utility [patent_app_number] => 13/289702 [patent_app_country] => US [patent_app_date] => 2011-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 27800 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0070/20120070862.pdf [firstpage_image] =>[orig_patent_app_number] => 13289702 [rel_patent_id] =>[rel_patent_doc_number] =>)